Public Relations  >  News Center  >  News Releases  >  December, 2012  >  December 12, 2012  >  Lynch Publishes Book on Personalized Cancer Care
Lynch Publishes Book on Personalized Cancer Care

Creighton University's hereditary cancer pioneer, Henry T. Lynch, M.D., serves as co-editor and major contributor to a new text book aimed to change the way clinicians approach the treatment of hereditary cancers.

Lynch, a professor of medicine at Creighton University School of Medicine and director of Creighton University's Hereditary Cancer Center, teamed with Dongfeng Tan, M.D., of the MD Anderson Cancer Center in Houston, Texas, to complete the book titled, "Principles of Molecular Diagnostics and Personalized Cancer Medicine."

"To my knowledge, this is the first book dealing with cancer which enunciates the need for a personalized medicine approach when dealing with hereditary forms of cancer," says Lynch.

Drs. Lynch and Tan co-edited 70 chapters written by a cadre of world-renowned experts in cancer research, pathology, clinical trials, molecular diagnostics, personalized therapy, bioinformatics and Federal regulations. Lynch also contributed to the book, including a chapter on genetic counseling from Creighton University's Department of Preventive Medicine.

"A personalized approach to treatment is about more than just offering a diagnosis," explains Lynch. "It is about taking patients by the hand and treating their minds and how they are feeling along with the pathology."

Often regarded as the father of hereditary cancer detection and prevention, Lynch pioneered the unique approach of using statistics to prove genetic links to certain cancer types in the 1960s. His early research significantly influenced how physicians and researchers treat and study hereditary cancers today. Hereditary nonpolyposis colorectal cancer (HNPCC), the most common form of hereditary colorectal cancer, is named Lynch syndrome after him.

"Principles of Molecular Diagnostics and Personalized Cancer Medicine," is now available for medical oncologists, pathologists, statisticians and any working physician who treats hereditary cancers.